Toyama Anti-arteriosclerosis and Plaque Assessment Trial by Aggressive Lipid Lowering Therapy with Pitavastatin in Peripheral Artery Disease
Not Applicable
- Conditions
- Patients with peripheral artery disease and hypercholesterolemia
- Registration Number
- JPRN-UMIN000003628
- Lead Sponsor
- The Second Department of Internal Medicine, University of Toyama, Graduate school of medicine and pharmaceutical science,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Following "contraindication" or "essentially contraindication" of pitavastatin as follows: severe liver injury or biliary obstruction patients taking cyclosporin pregnant or possible pregnant women or breast-feeding women patients with renal dysfunction and taking fibrates 2) patients already taking pitavastatin 3) patients with maintenance dialysis 4) patients who plan to undergo or underwent bilateral lower limb revascularization within within 3 months. 5) patients with severe peripheral artery disease (Fontaine classification class 4) 6) patient with previous cerebral hemorrhage 7) patients who judged inadequate by the co-execution doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method claudication time on Treadmill exercise test
- Secondary Outcome Measures
Name Time Method